Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Identifies perivascular adipose tissue as a potential therapeutic target in obesity-related.
B lood pressure (BP) regulation is a complex homeostatic process involving multiple organ systems, including the cardiovascular, renal, and central and peripheral nervous systems. 1 Inability to properly regulate BP can result in the development of hypertension, which is associated with an increased risk of stroke, myocardial infarction, and cardiac and renal failure, [2][3][4] and is the leading determinant of risk of death worldwide.5 In addition to genetic and environmental factors known to play a role in the development of hypertension, 6 body weight and obesity are highly correlated with hypertension in humans.7,8 This is particularly alarming given the increased prevalence of obesity, which now affects 1 in 3 people in the United States.9 The close association between obesity, hypertension, and other cardiovascular disorders suggests an important role for adipose tissue (AT) in the regulation of vascular tone and BP.Until the mid 1900s, AT was considered to be a form of connective tissue with the primary function of storing energy in the form of lipids.10 However, AT is now recognized to be an important endocrine organ that can secrete polypeptides and metabolites, known as adipokines, which are involved in the normal regulation of various physiological processes, including BP regulation and vascular function.10,11 In the setting of obesity, AT undergoes complex remodeling.This is marked by a significant increase in tissue mass, through adipocyte hyperplasia and hypertrophy.Changes in structural and cellular composition also occur, including changes in AT extracellular matrix, composition of lipid droplets, and infiltration of immune cells such as macrophages and lymphocytes, which results in low-grade inflammation.10,11 Most importantly, obesity shifts the secretory profile of AT, which in turn contributes to the dysregulation of BP and eventual development of hypertension.12 This is thought to occur through both direct actions of circulating adipokines on the vasculature and indirect actions through other systems, including the renal, central, and peripheral nervous system.Leptin, which is elevated in obesity, increases BP through activation of central nervous system pathways and enhanced sympathetic nervous system output.13,14 In addition, AT affects the renal system through renal compression with increased AT mass, as well as through activation of the renin-angiotensin-aldosterone system, of which all components are also expressed in AT and increased in obesity.15 Increased expression of proinflammatory adipokines in obesity, such as tumor necrosis factor-α, promotes vascular dysfunction through alterations in endothelial cell function and thickening of the vascular smooth muscle layer.This, in turn, leads to increased oxidative stress and stiffening of the vascular wall, promoting changes in vessel reactivity.16,17 The exact mechanisms by which AT regulates vascular function under normal conditions and obesity have been challenging to pinpoint due to location-dependent heterogeneity of AT phenotype.An increasing emphasis has been placed on understanding the role of AT surrounding the vasculature, known as perivascular AT (PVAT), given its location and potential role in paracrine and endocrine signaling.Here, we provide a brief review of the work assessing the role of PVAT in vascular regulation and the potential mechanisms by which PVAT may play a role in the development of hypertension and cardiovascular disease, with an emphasis on recently published work.We also highlight important unanswered questions in this emerging field.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: